For research and educational purposes only. Not medical advice.
Nefiracetam Reference
Educational, not medical advice reference for Nefiracetam: Nootropic, Cognitive; regulatory status, evidence posture, source review, and schedule notes. Also…
Reference summary
Trials in post-stroke apathy and depression in Japan and Europe; mixed results led to discontinued development.
- Categories
- Nootropic, Cognitive
- Aliases
- DM-9384
- Evidence posture
- human — Not FDA-approved. Trials in post-stroke apathy were discontinued. Community nootropic framing extrapolates from mixed trial data.
- Regulatory status
- No FDA-approved nefiracetam drug label. Japanese research compound with discontinued post-stroke depression and apathy trials.
- Content review status
- research reference